ImetelChat

Nicely done, thank you for your + activism.

#3 is the fire emoji question and answer!

Wow, by my check we are less than five weeks away from the day, and yes it will go all the way to the Friday before the stated date which is on a Sunday, IMO. As foreshadowed in the quarterly call, they are working on the labeling, which will be a non-event part of the Event, AIMO. (I mean it will b...

May 2nd -- Q1 Earnings Release (8:00am) May 9th -- Shareholder Meeting May 14th -- EHA Abstracts available online May 15th -- Updated 13F filings due (Updated stats on our Institutional Investors) I'm hoping for an EHA abstract on Lymphoma (pre-clinical) studies, but I'm not anticipating one. I sus...

Wow. Just wow.

Ha! Yep nothing left to do but enjoy the ride…

Yes it might be time to acknowledge what has happened since the ides of March… We finally, finally (finally) have had recognition of what everyone on this board has been screaming from the mountaintops for it looks like about a decade, Imetelstat is something special. It’s next generation ‘siblings’...

Dr. Feller was a rock star at the ODAC meeting. I’ll call back the mentions in each of the previous two quarterly calls that Dr. Scarlett stated that they contracted experts to prepare for and practice for the meeting. This preparation was clear, but it was also clear to me and assume most would agr...

The article was posted. Very encouraging.

So I say, it’s so nice post it twice.

All very good stuff. Keep finding those references

I’m seeing new underwriters in TD Cowen and Barclays. RA Capital headlines, assume they took 9.99% of offering to stay at 9.99%. Did not see a mention of NEA though. These investment firms are willing to pay $3 when they could have literally paid $1’s last week in the open market. Things have certai...

Yawn. I respectfully disagree. He is a journalist with no background in science, and has been nothing but biased, glib, and unimpressive with his tales on Geron. His “article” (blog) is nothing but more gaseous click bait. He is now getting people to read who had never heard of Geron, and people to ...

For those of you who didn't watch/listen to the ADCOM meeting, I recommend you listen to the public comments from Patient #3. Her story begins at the 4:32:07 mark of the video. https://www.youtube.com/watch?v=Om-cKKBsMS4 Many of us have "hung-in-there" for quite a while.....hoping the drug (and com...

He did state his rationale - that the risks ultimately outweighed the benefit. He bought into the FDA shaping of the cytopenias, despite multiple clinicians (and he would also know) that these are manageable in MDS centers. I think a real interesting moment was when the Dr from the Moffitt Center in...

Geron PR, AKA victory lap, today not posted here yet I don’t think: https://ir.geron.com/investors/press-releases/press-release-details/2024/Geron-Announces-FDA-Oncologic-Drugs-Advisory-Committee-Votes-in-Favor-of-the-Clinical-BenefitRisk-Profile-of-Imetelstat-for-the-Treatment-of-Transfusion-Depend...

Very entertaining... worst fear than any horror movie I have seen. Would have been perfect... except this is real life, impacting real patients and real families. I am ashamed at the incompetent FDA members and the panelist who voted no. May their family and friends never get this disease. Ash a bi...

Speakers 8 and 9 were patients. They were extremely compelling and 100% advocating for Imet. Dare I say, tear-jerkers...

9 Speakers was 9-0 in favor of Imetelstat.

Speaker #3 was a patient from TX, who said she was ready to meet the Lord upon hearing her treatments were not working. Before Imetelstat... needless to say, amazing story. Speaker #4 is Dr / expert from Cornell, non-sponsored who had consulted with Geron in the past.... "Enthusiastic to have Imetel...

Speaker #2 is equally "enthusiastic" (her word). She is a non-sponsor patient advocate with the MDS Foundation.

Seems the tide has definitely taking a decidedly (and maybe expected) +++ positive turn as the talk turns from anecdotes and real stories as compared to the data jargon...

Speaker #1 in the Open Hearing: MDS Doctor / expert in Canada. Had 3 patients in study and described experience of one, who was unblinded... She used the phrase "incredible drug", and "impressed". Halelujah moment for sure! Not that we did not know of these efficacy effects, however we did need this...

The Geron team and collaborators are indeed doing a great job. It’s hard not to characterize the FDA teams posture as being prosecuting attorneys. Ultimately this is nerve wracking as they are of course the ultimate arbiter as to if the drug is approved and the labeling. So I stick with my call that...